A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Infectious Disease Research Institute

ClinicalTrials.gov Identifier:

NCT01011309

First received: November 9, 2009

Last updated: July 23, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2011
Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)